LifeMD Inc (LFMD)
6.235
-0.76
(-10.86%)
USD |
NASDAQ |
Nov 14, 12:39
LifeMD Price: 6.235 for Nov. 14, 2024
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Nov 13, 2024 | 7.29 | 7.54 | 6.91 | 6.995 | 751550.0 |
| Nov 12, 2024 | 7.04 | 7.31 | 6.78 | 7.16 | 896793.0 |
| Nov 11, 2024 | 6.12 | 7.43 | 6.05 | 7.10 | 2.203M |
| Nov 08, 2024 | 5.50 | 6.14 | 5.34 | 5.85 | 1.735M |
| Nov 07, 2024 | 4.96 | 5.19 | 4.84 | 5.13 | 594643.0 |
| Nov 06, 2024 | 4.80 | 5.095 | 4.60 | 5.06 | 650100.0 |
| Nov 05, 2024 | 4.39 | 4.49 | 4.20 | 4.46 | 579163.0 |
| Nov 04, 2024 | 4.29 | 4.50 | 4.22 | 4.38 | 330833.0 |
| Nov 01, 2024 | 4.09 | 4.38 | 4.09 | 4.32 | 407150.0 |
| Oct 31, 2024 | 4.18 | 4.24 | 4.03 | 4.08 | 362997.0 |
| Oct 30, 2024 | 4.28 | 4.34 | 3.99 | 4.15 | 1.058M |
| Oct 29, 2024 | 4.39 | 4.39 | 4.26 | 4.31 | 200703.0 |
| Oct 28, 2024 | 4.35 | 4.46 | 4.32 | 4.395 | 241340.0 |
| Oct 25, 2024 | 4.29 | 4.47 | 4.255 | 4.29 | 217877.0 |
| Oct 24, 2024 | 4.40 | 4.40 | 4.22 | 4.25 | 267776.0 |
| Oct 23, 2024 | 4.39 | 4.56 | 4.30 | 4.39 | 390763.0 |
| Oct 22, 2024 | 4.61 | 4.61 | 4.41 | 4.42 | 291027.0 |
| Oct 21, 2024 | 4.75 | 4.79 | 4.47 | 4.49 | 557378.0 |
| Oct 18, 2024 | 4.60 | 4.79 | 4.60 | 4.68 | 349885.0 |
| Oct 17, 2024 | 4.75 | 4.755 | 4.53 | 4.58 | 249004.0 |
| Oct 16, 2024 | 4.82 | 4.91 | 4.61 | 4.76 | 457446.0 |
| Oct 15, 2024 | 4.61 | 4.84 | 4.45 | 4.82 | 525037.0 |
| Oct 14, 2024 | 4.41 | 4.90 | 4.41 | 4.64 | 855232.0 |
| Oct 11, 2024 | 4.21 | 4.50 | 4.21 | 4.38 | 629068.0 |
| Oct 10, 2024 | 4.46 | 4.46 | 4.10 | 4.21 | 854319.0 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
0.506
Minimum
Mar 12 2020
30.55
Maximum
Feb 17 2021
5.440
Average
4.56
Median
Jul 28 2023
Price Benchmarks
| Veradigm Inc | 11.00 |
| TruBridge Inc | 16.11 |
| Streamline Health Solutions Inc | 2.28 |
| LENZ Therapeutics Inc | 36.04 |
| Oruka Therapeutics Inc | 24.02 |
Price Related Metrics
| PS Ratio | 1.327 |
| Price to Free Cash Flow | 35.90 |
| Earnings Yield | -11.23% |
| Market Cap | 268.53M |